Citius Oncology CTOR
NASDAQ CTOR
$0.70 0.00 (-0.01%)
As of: Oct 22, 2026 · 11:27 AM EDT

Citius Oncology (CTOR) Change in Other Operating Assets (2023 - 2026)

Updated

Analysis

Citius Oncology (CTOR) Change in Other Operating Assets (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Assets Change (Qtr)
1 Eli Lilly 1,175.59 Bn 1,144.18 Bn 19.71 Bn -
2 Johnson & Johnson 639.41 Bn 557.93 Bn 17.26 Bn -950.00 Mn
3 AbbVie 502.56 Bn 475.67 Bn 12.70 Bn 188.00 Mn
4 Merck 375.27 Bn 329.65 Bn 12.21 Bn -
5 Novartis Ag 303.16 Bn 267.15 Bn 11.24 Bn -
6 Astrazeneca 268.63 Bn 242.32 Bn 12.86 Bn -
7 Amgen 242.12 Bn 197.52 Bn 7.24 Bn 330.00 Mn
8 Gilead Sciences 193.40 Bn 167.60 Bn 6.22 Bn 13.00 Mn
9 Pfizer 172.79 Bn 119.44 Bn 10.94 Bn -
10 Citius Oncology 75.54 Mn 45.13 Mn 1.00 Mn -221,107.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -221,107.00
Mar 31, 2026 -110,553.00
Dec 31, 2025 1.83 Mn
Jun 30, 2024 -20,338.00
Mar 31, 2024 35,610.00
Jun 30, 2023 -33,178.00
Mar 31, 2023 36,821.00
API Access

Citius Oncology Change in Other Operating Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-other-operating-assets&ticker=CTOR&period=max&api_key=YOUR_API_KEY